Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, Y.-H.
Right arrow Articles by Lee, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, Y.-H.
Right arrow Articles by Lee, S. N.
Journal of Clinical Oncology, Vol 21, Issue 16 (August), 2003: 3168-3170
© 2003 American Society for Clinical Oncology


DIAGNOSIS IN ONCOLOGY

Challenging Problems in Advanced Malignancy

CASE 1. CHYLOPERICARDIUM DURING THE TREATMENT OF NON-HODGKIN’S LYMPHOMA

You-Hyun Lee, Seock-Ah Im, Seung-Hyun Nam, Si-Nae Lee, Yookyung Kim, Chu-Myong Seong, Woon Sup Han, Sun Wha Lee, Seong-Hoon Park, Soon Nam Lee

Ewha Womans University, College of Medicine, Seoul, Korea

A 14-year-old boy presented with blood-tinged sputum and night sweats persisting for 3 months. He didn’t have any weight loss or fever. Physical examination showed facial edema, supraclavicular lymphadenopathy, and absence of hepatosplenomegaly. The complete blood analysis showed a hemoglobin level of 12.8 g/dL, a leukocyte count of 7,700/µL with normal differential count, and a platelet count of 297,000/µL. Other biochemical tests were within normal range, except for lactate dehydrogenase, which was 2,300 U/mL. A chest x-ray film showed a large mediastinal mass. A computed tomography (CT) scan of the thorax confirmed a multilobulated, heterogenous mass extending from the manubrium to the diaphragm, and measuring 8 x 8 x 14 cm (Fig 1AGo). The superior vena cava was markedly compressed and distorted (Fig 1AGo, arrow). Biopsy of the mass revealed a diffuse large-cell lymphoma (Fig 2AGo) of B-cell lineage (Fig 2BGo, L26-positive). Bone marrow aspiration and biopsy revealed invasion of lymphoma (stage IVB). Combination chemotherapy with cyclophosphamide, vincristine, doxorubicin, and dexamethasone plus intrathecal methotrexate and cytarabine was started. During the first cycle, dyspnea was markedly improved, and the mass size decreased. On day 17, sudden severe dyspnea developed. Tachycardia and decreased cardiac tones without murmurs were noted. Chest x-ray films showed new cardiomegaly, and ECG revealed a sinus tachycardia of 112 beat/min with low voltage. Echocardiography confirmed the presence of a moderate pericardial effusion with swinging heart image, but cardiac tamponade was not present (Fig 1BGo). A contrast-enhanced CT scan of the thorax also showed pericardial effusion of 2 cm in depth (Fig 1CGo). Lymphangiography showed a communication between lymphatics of thorax and cardiopericardiac space (Fig 1DGo). Pericardial drainage revealed 300 mL of a milky fluid (Fig 2CGo). Fluid analysis showed a triglyceride level of 1,330 mg/dL, a cholesterol level of 98 mg/dL, a protein level of 7.0 mg/dL, a leukocyte count of 170/µL (lymphocytes, 76%), no atypical cells, and negative cultures. Sudan III–stained fat droplets were found in the fluid (Fig 2DGo).



View larger version (107K):
[in this window]
[in a new window]
 
Fig 1. (A) Computed tomography (CT) scan of thorax (superior vena cava was markedly compressed and distorted, arrow); (B) echocardiography confirmed presence of moderate pericardial effusion, but cardiac tamponade was not present; (C) CT scan of thorax showed pericardial effusion of 2 cm in depth; (D) lymphangiography showed communication between lymphatics of thorax and cardiopericardiac space.

 


View larger version (136K):
[in this window]
[in a new window]
 
Fig 2. Biopsy of the mass showing (A) a diffuse large-cell lymphoma of (B) B-cell lineage. Pericardial drainage revealed (C) milky fluid with (D) Sudan III–stained fat.

 
The patient’s symptoms improved by pericardial drainage and a low-lipid diet. Nine days after pericardial drainage, the amount of chylous drainage was decreased to 2 mL per day, and the tube was removed. No reaccumulation of pericardial fluid was observed. He continued chemotherapy treatment.

The incidence of cardiac involvement by neoplasm in autopsy series is approximately 10%.1 The mechanical obstruction of lymphatic drainage is caused by postoperative or postirradiation fibrosis and superior vena cava syndrome. Chylopericardium is related to thoracic duct obstruction, with failure of adequate collateral drainage and resultant reflux of chylous lymph through lymphatics draining the heart and pericardium.2–4 When mechanical obstruction increases above 15 cm H2O pressure in lymphatic vessels, and when there is compression of venous collateral drainage, chylopericardium occurs.5 Although 44% of patients are asymptomatic, clinical features include dyspnea (39%), cough (12%), palpitation (3%), and chest pain (3%).2 These symptoms are similar to those observed from other pericardial effusions. Only pericardial fluid examination will give the correct diagnosis. Although the levels of fluid composition depend on the patient’s diet, chylous fluid is characterized by a milky appearance and cholesterol levels higher than 100 mg/dL, triglyceride levels over 1,000 mg/dL, and protein levels higher than 3 g/dL.2 The combination of lymphangiography with CT scan is an important diagnostic approach.6,7 Lymphangiography in our patient showed a connection between the thoracic duct and pericardium. In most cases, especially those associated with obstruction, a surgical approach, such as thoracic duct ligation and placement of a pleuropericardial window, may be necessary. Medical therapy should not be continued for longer than 2 weeks.6 Therapeutic goals are prevention of cardiac tamponade, constrictive pericarditis, and the loss of lymphatic fluid. Treatment usually begins with a diet rich in medium-chain triglycerides, which are directly absorbed into the portal venous system, to reduce the amount of lymph ascending into the thoracic lymphatics.4 Repeated pericardiocentesis or use of a pericardiostomy tube are necessary in less than 50% of patients.8 Our patient presented with superior vena cava syndrome caused by primary mediastinal, diffuse, large B-cell lymphoma. Isolated spontaneous chylopericardium during treatment was managed successfully only with pericardiocentesis and tube drainage. If pericardial effusion develops in non-Hodgkin’s lymphoma, chylopericardium should be considered as one of the differential diagnoses.

REFERENCES

1. Abraham KP, Reddy V, Gattuso P: Neoplasms metastatic to the heart: Review of 3314 consecutive autopsies. Am J Cardiovasc Pathol 3:195–198, 1990[Medline]

2. Dunn RP: Primary Chylopericardium: A review of the literature and an illustrated case. Am Heart J 89:369–377, 1975[CrossRef][Medline]

3. Groves LK, Effler DB: Primary chylopericardium. N Engl J Med 250:520–523, 1954[Medline]

4. Andrade Santiago J, Robles L, Casimiro C: Chylopericardium of neoplastic aetiology. Ann Oncol 9:1339–1342, 1998[Abstract/Free Full Text]

5. Csanády M, Kovásc GS: Isolated massive chylopericardium. Ann Thorac Surg 15:427–435, 1973[Medline]

6. Ruska M, Spaggiari L, Carbognani D, et al: Late spontaneous chylopericardium following complex cardiac surgery. J Cardiovasc Surg 36:175–176, 1995[Medline]

7. Akamatsu H, Amanu J, Sakamoto T, et al: Primary chylopericardium. Ann Thorac Surg 58:262–266, 1994[Abstract]

8. Chan BB, Murphy MC, Rodgers BM: Management of chylopericardium. J Pediatr Surg 25:1185–1189, 1990[CrossRef][Medline]





This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, Y.-H.
Right arrow Articles by Lee, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, Y.-H.
Right arrow Articles by Lee, S. N.

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online